logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
G

Geke A.P. Hospers

University of Groningen and University Medical Center Groningen
H指数:62
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

黑色素瘤新辅助治疗的五年生存率：国际黑色素瘤新辅助治疗协作组（INMC）更新的汇总分析

Nature Medicine
IF50
2026-10-010
OAAI
Georgina V. Long; Inês Pires da Silva; Kristen A. Perry; Jurriaan Romano; Serigne N. Lo; Piyush Grover; Paolo A. Ascierto; Rodabe N. Amaria; Tina J. Hieken; Caroline Robert; Lucie Heinzerling; Shahneen Sandhu; Milton Barros; Tara C. Mitchell; Zeynep Eroglu; Igor V. Samoylenko; Lukas Flatz; Céleste Lebbé; Douglas B. Johnson; Piotr Rutkowski; Eva Muñoz-Couselo; Omid Hamid; Claudia Trojaniello; Domenico Mallardo; Matthew S. Block; Naima Hammoudi; Naima Benannoune; Dirk Tomsitz; Yang Wang; Cigdem Dinckal; Angelina Kuzmenko; Andrea Forschner; Matteo S. Carlino; Mathilde Jalving; Michael A. Postow; P. Francesco Ferrucci; Ellen Kapiteijn; Astrid A. M. van der Veldt; Karijn P. M. Suijkerbuijk; Laetitia da Meda; Hannah Burnette; Anna Czarnekca; Inderjit Mehmi; Geke Hospers; Sarah Lochrin; Alexander C. J. van Akkooi; Hussein A. Tawbi; Elizabeth M. Burton; Michael T. Tetzlaff; Bart A. van de Wiel; Robert V. Rawson; Christian U. Blank; Alexander M. Menzies
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling

通过血浆谱分析确定的癌症免疫治疗结果的代谢决定因素

Nature Medicine
IF50
2026-06-250
OAAI
Déborah Suissa; Marine Fidelle; Ella Reich; Thao-Nguyen Pham; Simon Thomas; Johannes R. Björk; Peng Liu; Liwei Zhao; Koji Kitaoka; Eléonore Piard; Isabelle Lebhar; Ai-Ling Tian; Cassandra Thelemaque; Carolina Alves Costa Silva; Eric Deutsch; Yohann Loriot; Nicola Segata; Gianmarco Piccinno; Geke A. P. Hospers; Saman Maleki Vareki; Michael S. Silverman; John G. Lenehan; Véronique Bataille; David Boulate; Tatiana Kuznetsova; Rinse K. Weersma; Meriem Messaoudene; Sylvère Durand; Carlijn M. van der Aalst; Harry J. de Koning; Beatrice Schuler-Thurner; I. Jolanda M. de Vries; Edmond Rafie; Renée Maria Saliby; Marc Machaalani; Sebastian Haferkamp; Bastian Schilling; Serena Porcari; Chiara Ciccarese; Roberto Iacovelli; Chiara Cremolini; Toni K. Choueiri; Arielle Elkrief; Guido Kroemer; Lucie Heinzerling; Kenji Chamoto; Gianluca Ianiro; Bertrand Routy; Lisa Derosa; Nikos Paragios; Laurence Zitvogel
AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response

基于人工智能的病理组织学分析预测晚期黑色素瘤对检查点抑制剂的反应并识别与反应相关的模式

European Journal of Cancer
IF7.1
2026-05-250
OAAI
Mark Schuiveling; Isabella A.J. van Duin; Laurens S. ter Maat; Janneke C. van der Weerd; Rik J. Verheijden; Franchette van den Berkmortel; Christian U. Blank; Gerben E. Breimer; Femke H. Burgers; Marye Boers-Sonderen; Mariette Labots; Jan Willem B. de Groot; John B.A.G. Haanen; Geke A.P. Hospers; Ellen Kapiteijn; Djura Piersma; Lieke Simkens; Hans M. Westgeest; Anne M.R. Schrader; Josien P.W. Pluim
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial

黑色素瘤的新辅助治疗ipilimumab联合nivolumab: 来自2期PRADO试验的5年生存率和生物标志物分析

Nature Medicine
IF50
2026-01-280
PRE
Lotte L. Hoeijmakers; Petros Dimitriadis; Steven C. M. A. Wijnen; Irene L. M. Reijers; Marta Lopez-Yurda; Alexander M. Menzies; Annegien Broeks; Sten Cornelissen; Alejandro Torres Acosta; Anja van der Wal; Robyn P. M. Saw; Judith M. Versluis; Winan J. van Houdt; Michel W. Wouters; Jurriaan Romano; Eliza A. Rozeman; Lindsay G. Grijpink-Ongering; Ellen Kapiteijn; Astrid A. M. van der Veldt; Karijn P. M. Suijkerbuijk; Hanna Eriksson; Geke A. P. Hospers; Jos A. van der Hage; Dirk J. Grünhagen; Arjen J. Witkamp; Judith M. Lijnsvelt; Willem M. C. Klop; Charlotte L. Zuur; Annemarie Bruining; Abrahim Al-Mamgani; Thomas E. Pennington; Kerwin F. Shannon; Sydney Ch’ng; Andrew J. Colebatch; Maria Gonzalez; Andrew J. Spillane; John B. A. G. Haanen; Robert V. Rawson; Richard A. Scolyer; Bart A. van de Wiel; Alexander C. J. van Akkooi; Georgina V. Long; Christian U. Blank
Induction therapy with BRAF/MEK inhibitors versus upfront ipilimumab/nivolumab in poor prognostic advanced melanoma

使用BRAF/MEK抑制剂进行诱导治疗与一线使用ipilimumab/nivolumab治疗预后不良的晚期黑色素瘤

European Journal of Cancer
IF7.1
2025-10-200
OAAI
M. Bloem; A.J.M. van den Eertwegh; J.B.A.G. Haanen; M.J.B. Aarts; F.W.P.J. van den Berkmortel; C.U. Blank; W.A.M. Blokx; M.J. Boers-Sonderen; C.D.M. Boreel; J.W.B. de Groot; G.A.P. Hospers; E. Kapiteijn; D. Piersma; B. Rikhof; L.H.J. Simkens; A.M Stevense-den Boer; A.A.M. van der Veldt; M.W.J.M. Wouters; K.P.M. Suijkerbuijk
Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study

妊娠期晚期黑色素瘤：一项回顾性、多中心、基于注册研究的建议

eClinicalMedicine
IF10
2025-10-070
OAAI
Jessica S.W. Borgers; Douglas B. Johnson; Elisabeth Livingstone; Dirk Schadendorf; Elizabeth I. Buchbinder; Lauren E. Haydu; Laura Gohil; William A. Robinson; Inderjit Mehmi; Omid Hamid; Michelle Ferreira; April K.S. Salama; Florentia Dimitriou; Matteo S. Carlino; Georgina V. Long; Paolo A. Ascierto; Ester Simeone; Yana G. Najjar; Geke A.P. Hospers; Jacob Choi; Sunandana Chandra; Jeffrey D. Wayne; Carlos I.R. García; Wen Xu; Céleste Lebbé; Laetitia Da-Meda; Victoria Atkinson; Meredith Mckean; Andrea Forschner; Elliot A. Asare; Antonios Daletzakis; Jolyn S. Taylor; Frédéric Amant; Katy K. Tsai; Zeynep Eroglu; John B.A.G. Haanen; Isabella C. Glitza de Oliva
Comparative analysis of FES-PET/CT and FDG-PET/CT in patients with ER-positive metastatic invasive lobular breast cancer

FES-PET/CT与FDG-PET/CT在ER阳性转移性浸润性小叶乳腺癌患者中的比较分析

European Journal of Cancer
IF7.1
2025-09-130
PREAI
Jasmine Moustaquim; Gabriëlle E. van Wonderen; Jasper J.L. van Geel; Michel van Kruchten; Erik F.J. de Vries; Agnes Jager; Evelien Kuip; Marcel P.M. Stokkel; Andor W.J.M. Glaudemans; Adrienne H. Brouwers; Geke A.P. Hospers; C. Willemien Menke-van der Houven van Oordt; Bert van der Vegt; Elisabeth G.E. de Vries; Carolina P. Schröder
Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial

RAPIDO试验中，总新辅助治疗后与化放疗后局部晚期直肠癌局部区域复发率的影响因素

BJS
IF8.7
2025-09-020
PRE
Ilaria Prata; Max D Tanaka; Bengt Glimelius; Iris D Nagtegaal; Regina G H Beets-Tan; Lennart K Blomqvist; Alice M Couwenberg; Boudewijn van Etten; Geke A P Hospers; Elma Meershoek-Klein Kranenbarg; Koen C M J Peeters; Hein Putter; Annet G H Roodvoets; Cornelis J H van de Velde; Per J Nilsson; Corrie A M Marijnen
Acute and Late Radiation-Related Toxicity After Treatment of Locally Advanced Rectal Cancer With Intensity Modulated Radiation Therapy Compared With 3-Dimensional Conformal Radiation Therapy in the RAPIDO Trial

在RAPIDO试验中，与三维适形放射治疗相比，采用调强放射治疗局部晚期直肠癌后的急性期和晚期放射相关毒性。

international journal of radiation oncology biology physics
IF0
2025-05-100
PRE
Max D. Tanaka; Bengt Glimelius; Geke A.P. Hospers; Elma Meershoek-Klein Kranenbarg; Corrie A.M. Marijnen; Hein Putter; Annet G.H. Roodvoets; Cornelis J.H. van de Velde; Boudewijn van Etten; Per J. Nilsson; Alice M. Couwenberg
Impact of extending the original criteria in the Chemoradiotherapy for Oesophageal Cancer followed by Surgery Study (CROSS) regimen on treatment outcome in locally advanced esophageal cancer patients

扩展Chemoradiotherapy for Oesophageal Cancer followed by Surgery Study (CROSS)方案中原有标准的对局部晚期食管癌患者治疗效果的影响

ESMO OPEN
IF8.3
2025-05-010
OA
Wang, H. H.; Nolte, I. M.; Verhoeven, R. H. A.; Oppedijk, V.; van Etten, B.; Kats-Ugurlu, G.; Plukker, J. T. M.; Hospers, G. A. P.
Rechallenge of ipilimumab and nivolumab in advanced melanoma patients after previous ipilimumab-based therapy

在既往接受过ipilimumab为基础治疗方案的患者中，对晚期黑色素瘤患者进行ipilimumab和nivolumab的重新挑战治疗

BRITISH JOURNAL OF CANCER
IF6.8
2025-04-290
PRE
van Dijk, E. J.; Nienhuis, H. H.; van den Eertwegh, A. J. M.; Boers-Sonderen, M. J.; Bloem, M.; Kamphuis, A. M.; Ros, M. M.; Bos, C.; Aarts, M. J. B.; van den Berkmortel, F. W. P. J.; Blank, C. U.; Blokx, W. A. M.; de Groot, J. W. B.; Hospers, G. A. P.; Piersma, D.; van Rijn, R. S.; Stevense-den Boer, A. M.; Vreugdenhil, G.; Wouters, M. W. J. M.; Kapiteijn, E.; Haanen, J. B.; van der Veldt, A. A. M.; Suijkerbuijk, K. P. M.
Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis

辅助BRAF/MEK与抗PD-1在BRAF突变黑色素瘤中的倾向性评分匹配生存分析

BRITISH JOURNAL OF CANCER
IF6.8
2025-04-150
PRE
Bloem, M.; de Meza, M. M.; van den Eertwegh, A. J. M.; Aarts, M. J. B.; van den Berkmortel, F. W. P. J.; Blank, C. U.; Blokx, W. A. M.; Boers-Sonderen, M. J.; Bonenkamp, J. J.; Boreel, C. D. M.; de Groot, J. W. B.; Haanen, J. B. A. G.; Hospers, G. A. P.; Kapiteijn, E.; van Not, O. J.; Piersma, D.; Rikhof, B.; Stevense-den Boer, A. M.; van der Veldt, A. A. M.; Vreugdenhil, G.; Suijkerbuijk, K. P. M.; Wouters, M. W. J. M.
Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model

荷兰使用卫生经济模型评估BRAF突变型晚期黑色素瘤治疗顺序的成本效益

EUROPEAN JOURNAL OF CANCER
IF7.1
2025-03-010
PRE
Blommestein, Hedwig M.; de Groot, Saskia; Leeneman, Brenda; Uyl-de Groot, Carin A.; Haanen, John B. A. G.; Wouters, Michel W. J. M.; Aarts, Maureen J. B.; van den Berkmortel, Franchette W. P. J.; Blokx, Willeke A. M.; Boers-Sonderen, Marye J.; van den Eertwegh, Alfons J. M.; de Groot, Jan Willem B.; Hospers, Geke A. P.; Kapiteijn, Ellen; van Not, Olivier J.; Veldt, Astrid A. M. van der; Suijkerbuijk, Karijn P. M.; Franken, Margreet G.
Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma

开发决策模型以估计晚期黑色素瘤治疗序列的结果

MEDICAL DECISION MAKING
IF2.3
2025-02-221
OAAI
de Groot, Saskia; Blommestein, Hedwig M.; Leeneman, Brenda; Uyl-de Groot, Carin A.; Haanen, John B. A. G.; Wouters, Michel W. J. M.; Aarts, Maureen J. B.; van den Berkmortel, Franchette W. P. J.; Blokx, Willeke A. M.; Boers-Sonderen, Marye J.; van den Eertwegh, Alfons J. M.; de Groot, Jan Willem B.; Hospers, Geke A. P.; Kapiteijn, Ellen; van Not, Olivier J.; van der Veldt, Astrid A. M.; Suijkerbuijk, Karijn P. M.; van Baal, Pieter H. M.
Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry [Eur. J. Cancer 212, 2024, 115056]

辅助免疫疗法在III期和已切除IV期黑色素瘤老年患者中的应用：来自荷兰黑色素瘤治疗登记研究的毒性和无复发生存结果 [Eur. J. Cancer 212, 2024, 115056]

EUROPEAN JOURNAL OF CANCER
IF7.1
2025-02-010
PRE
Ozkan, A.; Kapiteijn, E.; van den Bos, F.; Aarts, M. J. B.; van den Berkmortel, F. W. P. J.; Blank, C. U.; Bloem, M.; Blokx, W. A. M.; Boers-Sonderen, M. J.; Bonenkamp, J. J.; van den Eertwegh, A. J. M.; de Groot, J. W. B.; Haanen, J. B.; Holtslag, C. E.; Hospers, G. A. P.; Piersma, D.; van Rijn, R. S.; Stevense-den Boer, A. M.; Suijkerbuijk, K. P. M.; van der Veldt, A. A. M.; Vreugdenhil, G.; Wouters, M. W. J. M.; Portielje, J. E. A.; de Glas, N. A.
Intrapatient 16a-[18F]Fluoro-17b-Estradiol PET Heterogeneity as a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer

患者体内16a-[18F]氟-17b-雌二醇PET异质性作为雌激素受体阳性转移性乳腺癌患者内分泌治疗反应和生存的预后因素

JOURNAL OF NUCLEAR MEDICINE
IF9.1
2025-01-231
PRE
van Geel, Jasper J. L.; Moustaquim, Jasmine; Boers, Jorianne; Elias, Sjoerd G.; Smeets, Esther M. M.; Knip, Jelijn J.; Glaudemans, Andor W. J. M.; de Vries, Erik F. J.; Hospers, Geke A. P.; van Kruchten, Michel; Stokkel, Marcel; Oprea-Lager, Daniela E.; Menke-van der Houven van Oordt, Willemien C.; de Vries, Elisabeth G. E.; Schroder, Carolina P.; IMPACT-Metastatic Breast Consortium

研究方向

暂未获取到该数据
E
Ellen Kapiteijn
H 指数:52论文数:479被引数:1.6万
K
Karijn P.M. Suijkerbuijk
H 指数:36论文数:267被引数:8,539
M
Michel W.J.M. Wouters
H 指数:64论文数:654被引数:1.6万
D
Djura Piersma
H 指数:27论文数:165被引数:3,107
A
Astrid A.M. van der Veldt
H 指数:44论文数:360被引数:6,856
M
Maureen J.B. Aarts
H 指数:36论文数:265被引数:6,575
J
John B.A.G. Haanen
H 指数:109论文数:931被引数:9.7万
G
Gerard Vreugdenhil
H 指数:49论文数:331被引数:8,249
F
Franchette W.P.J. van den Berkmortel
H 指数:28论文数:201被引数:3,623
C
Christian U. Blank
H 指数:95论文数:670被引数:5.8万